Diebold Nixdorf, Incorporated
DBD
$79.79
-$1.45-1.79%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.10B | 945.20M | 915.20M | 841.10M | 988.90M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.10B | 945.20M | 915.20M | 841.10M | 988.90M |
| Cost of Revenue | 804.50M | 697.30M | 672.50M | 627.90M | 752.50M |
| Gross Profit | 299.70M | 247.90M | 242.70M | 213.20M | 236.40M |
| SG&A Expenses | 151.10M | 141.00M | 147.90M | 145.00M | 159.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -200.00K | 100.00K | 100.00K | -1.70M | 300.00K |
| Total Operating Expenses | 976.40M | 858.80M | 842.70M | 791.50M | 934.70M |
| Operating Income | 127.80M | 86.40M | 72.50M | 49.60M | 54.20M |
| Income Before Tax | 62.40M | 51.30M | 17.50M | -9.70M | 11.90M |
| Income Tax Expenses | 11.90M | 9.60M | 4.80M | -2.20M | 5.50M |
| Earnings from Continuing Operations | 50.50M | 41.70M | 12.70M | -7.50M | 6.40M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -900.00K | -600.00K | -500.00K | -800.00K | -800.00K |
| Net Income | 49.60M | 41.10M | 12.20M | -8.30M | 5.60M |
| EBIT | 127.80M | 86.40M | 72.50M | 49.60M | 54.20M |
| EBITDA | 147.20M | 118.10M | 103.70M | 83.50M | 88.90M |
| EPS Basic | 1.39 | 1.13 | 0.33 | -0.22 | 0.15 |
| Normalized Basic EPS | 1.86 | 1.08 | 0.55 | 0.15 | 0.51 |
| EPS Diluted | 1.36 | 1.11 | 0.33 | -0.22 | 0.15 |
| Normalized Diluted EPS | 1.83 | 1.06 | 0.55 | 0.15 | 0.51 |
| Average Basic Shares Outstanding | 35.80M | 36.50M | 37.20M | 37.60M | 37.60M |
| Average Diluted Shares Outstanding | 36.30M | 37.00M | 37.50M | 37.60M | 37.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |